# Novo Nordisk

**Canonical:** https://apis.io/providers/novo-nordisk/  
**Website:** https://www.novonordisk.com/  
**APIs profiled:** 0

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, and the world leader in diabetes care. The company also develops treatments for obesity, rare blood disorders, and growth-hormone therapy, including its widely known GLP-1 medicines Ozempic, Wegovy, and Rybelsus. Novo Nordisk does not publish a public commercial developer API. The company maintains a research GitHub organization (novonordisk-research) that releases open-source scientific computing libraries and an SDK for the Waters Empower Web API (OptiHPLCHandler) used in pharmaceutical analytical chemistry workflows.

## Kin Score — 3.7 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Novo Nordisk Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Pharmaceuticals, Healthcare, Biotechnology, Diabetes, Obesity, Open Source Research

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/novo-nordisk/). Scores are computed from the provider's own public artifacts under a published rubric.